-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
DICE Therapeutics, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q3 2020 to Q2 2023.
- DICE Therapeutics, Inc. General and Administrative Expense for the quarter ending June 30, 2023 was $11.3M, a 52.4% increase year-over-year.
- DICE Therapeutics, Inc. General and Administrative Expense for the twelve months ending June 30, 2023 was $32M, a 50.3% increase year-over-year.
- DICE Therapeutics, Inc. annual General and Administrative Expense for 2022 was $25.7M, a 110% increase from 2021.
- DICE Therapeutics, Inc. annual General and Administrative Expense for 2021 was $12.2M, a 144% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)